<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Herrera VL</submitter><funding>NCATS NIH HHS</funding><funding>National Cancer Institute</funding><funding>BU CTSI award</funding><funding>NCI NIH HHS</funding><funding>BU Office of Technology Development</funding><pagination>15</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4906906</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>In contrast to rat and mouse databases, the NCBI gene database lists the human dual-endothelin1/VEGFsp receptor (DEspR, formerly Dear) as a unitary transcribed pseudogene due to a stop [TGA]-codon at codon#14 in automated DNA and RNA sequences. However, re-analysis is needed given prior single gene studies detected a tryptophan [TGG]-codon#14 by manual Sanger sequencing, demonstrated DEspR translatability and functionality, and since the demonstration of actual non-translatability through expression studies, the standard-of-excellence for pseudogene designation, has not been performed. Re-analysis must meet UNIPROT criteria for demonstration of a protein's existence at the highest (protein) level, which a priori, would override DNA- or RNA-based deductions.&lt;h4>Methods&lt;/h</pubmed_abstract><journal>BMC molecular biology</journal><pubmed_title>Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein.</pubmed_title><pmcid>PMC4906906</pmcid><funding_grant_id>5P30CA045508</funding_grant_id><funding_grant_id>P30 CA045508</funding_grant_id><funding_grant_id>U54 TR001012</funding_grant_id><funding_grant_id>NIH-U54TR001012</funding_grant_id><pubmed_authors>Steffen M</pubmed_authors><pubmed_authors>Ruiz-Opazo N</pubmed_authors><pubmed_authors>Pappin DJ</pubmed_authors><pubmed_authors>Tan GA</pubmed_authors><pubmed_authors>Pasion KA</pubmed_authors><pubmed_authors>Herrera VL</pubmed_authors><pubmed_authors>Moran AM</pubmed_authors><pubmed_authors>Rivera K</pubmed_authors></additional><is_claimable>false</is_claimable><name>Confirmation of translatability and functionality certifies the dual endothelin1/VEGFsp receptor (DEspR) protein.</name><description>&lt;h4>Background&lt;/h4>In contrast to rat and mouse databases, the NCBI gene database lists the human dual-endothelin1/VEGFsp receptor (DEspR, formerly Dear) as a unitary transcribed pseudogene due to a stop [TGA]-codon at codon#14 in automated DNA and RNA sequences. However, re-analysis is needed given prior single gene studies detected a tryptophan [TGG]-codon#14 by manual Sanger sequencing, demonstrated DEspR translatability and functionality, and since the demonstration of actual non-translatability through expression studies, the standard-of-excellence for pseudogene designation, has not been performed. Re-analysis must meet UNIPROT criteria for demonstration of a protein's existence at the highest (protein) level, which a priori, would override DNA- or RNA-based deductions.&lt;h4>Methods&lt;/h</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Jun</publication><modification>2026-06-15T07:05:34.119Z</modification><creation>2019-03-27T02:15:59Z</creation></dates><accession>S-EPMC4906906</accession><cross_references><pubmed>27301377</pubmed><doi>10.1186/s12867-016-0066-8</doi></cross_references></HashMap>